Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Unilever Q1 Revenues Climb On Emerging Markets' Strength - Quick Facts

RELATED NEWS
Trade UL now with 

Anglo-Dutch consumer products maker Unilever (UN,UL: Quote, ULVR.L) on Thursday reported that its first-quarter turnover increased 11.9 percent from last year with growth in all categories and regions, despite sluggish economies, weak consumer confidence in many markets and sustained levels of competitive intensity.

Turnover grew to 12.14 billion euros from last year's 10.86 billion euros. The company noted that acquisitions net of disposals contributed 2.7 percent to turnover.

Underlying sales growth, excluding acquisitions, was 8.4 percent as all categories contributing to growth, with emerging markets, now 56 percent of the business, up 11.9 percent and developed markets up 4.2 percent.

Underlying volume growth was 3.5 percent and pricing grew 4.7 percent

In the quarter, personal care revenues climbed 20.9 percent, and foods revenues grew 5.5 percent. The growth was 9.2 percent in home care and 9.3 percent in refreshment segments. All three regions also posted higher revenues in the quarter.

The Boards have declared a quarterly interim dividend of 0.243 euros per share for the quarter, up 8 percent from last year.

Chief Executive Officer Paul Polman said, "The external macro-economic environment remains difficult and higher input cost headwinds persist. Our long term priorities remain unchanged - profitable volume growth ahead of our markets, steady and sustainable core operating margin improvement and strong cash flow."

"For 2012, we remain on track to deliver a modest improvement in full year core operating margin, weighted towards the second half of the year," he added.

Register
To receive FREE breaking news email alerts for Unilever PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.